Lineagen
Latest round
- Series C
Last raised
- Jan 2015
Total raised
- $54M
Investors
- 13
About Lineagen
Lineagen Inc.Lineagen Inc. was founded in 2002 and is headquartered in Salt Lake City, US. The company specializes in genetic testing services aimed at understanding pediatric neurodevelopmental disorders. In August 2020, Lineagen was acquired by BioNano Genomics, Inc.6 million.Lineagen, Inc. specializes in advanced genetic testing and analysis services, particularly targeting pediatric neurodevelopmental disorders such as autism spectrum disorder and developmental delays. Their core offerings include a range of genetic tests, such as the FirstStep Dx PLUS Chromosomal Microarray and NextStep Dx PLUS Whole Exome Sequencing, which provide vital clinical insights for healthcare providers. Additionally, they offer Optical Genome Mapping (OGM) services, facilitating research into structural variations in the genome, catering to both clinicians and researchers exploring genetic implications in various medical conditions.Lineagen's revenue model relies on direct transactions with healthcare providers and researchers seeking genetic testing services for their patients or studies. The company engages in B2B transactions, offering specialized genetic testing solutions including flagship products like the OGM-Dx series for postnatal and prenatal testing. They have established flexible pricing structures catering to various scales of testing, ensuring accessibility for both large institutions and individual practitioners. The ordering process is designed to facilitate ease of access to their offerings, ensuring a smooth experience from initial consultation to result delivery.Following the acquisition by BioNano Genomics, Inc. in August 2020, Lineagen is expected to leverage its new resources to enhance its product offerings and expand into new markets. The company is actively developing new genetic testing products aimed at further improving clinical outcomes in pediatric healthcare. Additionally, plans are underway to enter new geographic regions to meet the growing demand for genetic testing services.
Who invested in Lineagen
13 investors across 5 rounds
See all investors in Lineagen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lineagen
Who invested in Lineagen?
Lineagen has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lineagen raised?
Lineagen has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Lineagen last raise money?
Lineagen's most recent round on record is a Series C, in Jan 2015.
What does Lineagen do?
Lineagen is a biotechnology company.
Where is Lineagen headquartered?
Lineagen is headquartered in Salt Lake City, US.
Which VCs invest in companies like Lineagen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lineagen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Lineagen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.